Effects of tumour necrosis factor-alpha on activity and nitric oxide synthase of endothelial progenitor cells from peripheral blood

Cell Proliferation

Volumn 44, Issue 4, 2011, Pages 352-359

  Chen, T G ^a   Zhong, Z Y ^a   Sun, G F ^a   Zhou, Y X ^a   Zhao, Y ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBRONECTIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LECTIN; LIPOCORTIN 5; MESSENGER RNA; NITRIC OXIDE SYNTHASE; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN RECEPTOR 1;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL ASSAY; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; ENDOTHELIAL PROGENITOR CELL; FLUORESCENCE; HUMAN; HUMAN CELL; LECTIN BINDING; MODIFIED BOYDEN CHAMBER ASSAY; MONONUCLEAR CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUBE FORMATION ASSAY; WESTERN BLOTTING;

ADULT; APOPTOSIS; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CXCL12; ENDOTHELIAL CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; STEM CELLS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 79959751427     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2011.00764.x     Document Type: Article

References (29)

1. Wilson SH, Best PJ, Edwards WD, Holmes DR Jr, Carlson PJ, Celermajer DS et al. (2002) Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris. Atherosclerosis 160, 147-153.
2. Urbich C, Dimmeler S (2005) Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int. 67, 1672-1676.
3. Guo X, Chen LW, Liu WL, Guo ZG (2000) High glucose inhibits expression of inducible and constitutive nitric oxide synthase in bovine aortic endothelial cells. Acta Pharmacol. Sin. 21, 325-328.
4. Chen TG, Chen JZ, Xie XD (2006a) Effects of aspirin on number, activity and inducible nitric synthase of endothelial progenitor cells from peripheral blood. Acta Pharmacol. Sin. 27, 430-436.
5. Chen TG, Chen JZ, Wang XX (2006b) Effects of rapamycin on number, activity and eNOS of endothelial progenitor cells from peripheral blood. Cell Prolif. 39, 117-125.
6. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA et al. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348, 593-600.
7. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M et al. (2000) Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA 97, 3422-3427.
8. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM et al. (2001a) Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103, 2885-2890.
9. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H et al. (2001b) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Cir. Res. 89, E1-E7.
10. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T et al. (2002) Statin therapy accelerate reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105, 3017-3024.
11. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM (2002) Origin of endothelial progenitors in human postnatal bone marrow. J. Clin. Invest. 109, 337-346.
12. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR et al. (2002) Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106, 2781-2786.
13. Henrich D, Seebach C, Wilhelm K, Marzi I (2007) High dosage of simvastatin reduces TNF-alpha-induced apoptosis of endothelial progenitor cells but fails to prevent apoptosis induced by IL-1beta in vitro. J. Surg. Res. 142, 13-19.
14. Xu J, Liu X, Chen J, Zacharek A, Cui X, Savant-Bhonsale S et al. (2010) Cell-cell interaction promotes rat marrow stromal cell differentiation into endothelial cell via activation of TACE/TNF-alpha signaling. Cell Transplant. 19, 43-53.
15. Zhang C, Xu X, Potter BJ, Wang W, Kuo L, Michael L et al. (2006) TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury. Arterioscler. Thromb. Vasc. Biol. 26, 475-480.
16. Goukassian DA, Qin G, Dolan C, Murayama T, Silver M, Curry C et al. (2007) Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization. Circulation 115, 752-762.
17. Dutta D, Ray S, Vivian JL, Paul S (2008) Activation of the VEGFR1 chromatin domain an angiogenic signal-ETS1/HIF-2α regulatory axis. J. Biol. Chem. 283, 25404-25413.
18. Xiao Q, Ye S, Oberhollenzer F, Mayr A, Jahangiri M, Willeit J et al. (2008) SDF1 gene variation is associated with circulating SDF1alpha level and endothelial progenitor cell number: the Bruneck Study. PLoS One 3, e4061.
19. Anderson HD, Rahmutula D, Gardner DG (2004) Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells. J. Biol. Chem. 279, 963-969.
20. Murayama T, Tepper OM, Silver M, Ma H, Losordo DW, Isner JM et al. (2002) Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization. Exp. Hematol. 30, 967-972.
21. Suzuki T, Nishida M, Futami S, Fukino K, Amaki T, Aizawa K et al. (2003) Neoendothelialization after peripheral blood stem cell transplantation in humans. A case report of a Tokaimura nuclear accident victim. Cardiovasc. Res. 58, 487-492.
22. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H et al. (2000) Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J. Clin. Invest. 105, 1527-1536.
23. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA (2000) Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J. Clin. Invest. 106, 571-578.
24. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J et al. (2001) Neovascularization of ischemic myocardium by human bone-marrowderived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7, 430-436.
25. Mehta JL, Li DY (1999) Inflammation in ischemic heart disease: response to tissue injury or a pathogenetic villain. Cardiovasc. Res. 43, 291-299.
26. Fernandez L, Rodriguez S, Huang H, Chora A, Fernandes J, Mumaw C et al. (2008) Tumor necrosis factor-alpha and endothelial cells modulate Notch signaling in the bone marrow microenvironment during inflammation. Exp. Hematol. 36, 545-558.
27. Padfield GJ, Tura O, Haeck ML, Short A, Freyer E, Barclay GR et al. (2010) Circulating endothelial progenitor cells are not affected by acute systemic inflammation. Am. J. Physiol. Heart Circ. Physiol. 298, H2054-H2061.
28. Kuruvilla L, Kartha CC (2009) Treatment with TNF-alpha or bacterial lipopolysaccharide attenuates endocardial endothelial cell-mediated stimulation of cardiac fibroblasts. J. Biomed. Sci. 16, 21.
29. Walter DH, Dimmeler S, Zeiher AM (2004) Effects of statins on endothelium and endothelial progenitor cell recruitment. Semin. Vasc. Med. 4, 385-393.